Research ArticleADULT BRAIN
Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade Gliomas
D. Daniels, D. Guez, D. Last, C. Hoffmann, D. Nass, A. Talianski, G. Tsarfaty, S. Salomon, A.A. Kanner, D.T. Blumenthal, F. Bokstein, S. Harnof, D. Yekutieli, S. Zamir, Z.R. Cohen, L. Zach and Y. Mardor
American Journal of Neuroradiology July 2016, DOI: https://doi.org/10.3174/ajnr.A4866
D. Daniels
From the Oncology Institute (L.Z., A.T.), Advanced Technology Center (D.G., D.L., D.D., S.S., Y.M.), Department of Neurosurgery (Z.R.C., S.H.), Radiology Institute (C.H., G.T.), and Pathology Institute (D.N.), Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine (L.Z., D.D., C.H., G.T., Z.R.C., Y.M., S.H.) and School of Mathematical Sciences (D.Y., S.Z.), Tel-Aviv University, Tel-Aviv, Israel; and Neuro- Oncology Service (D.T.B., F.B.) and Stereotactic Radiosurgery Unit (A.A.K.), Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
D. Guez
From the Oncology Institute (L.Z., A.T.), Advanced Technology Center (D.G., D.L., D.D., S.S., Y.M.), Department of Neurosurgery (Z.R.C., S.H.), Radiology Institute (C.H., G.T.), and Pathology Institute (D.N.), Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine (L.Z., D.D., C.H., G.T., Z.R.C., Y.M., S.H.) and School of Mathematical Sciences (D.Y., S.Z.), Tel-Aviv University, Tel-Aviv, Israel; and Neuro- Oncology Service (D.T.B., F.B.) and Stereotactic Radiosurgery Unit (A.A.K.), Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
D. Last
From the Oncology Institute (L.Z., A.T.), Advanced Technology Center (D.G., D.L., D.D., S.S., Y.M.), Department of Neurosurgery (Z.R.C., S.H.), Radiology Institute (C.H., G.T.), and Pathology Institute (D.N.), Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine (L.Z., D.D., C.H., G.T., Z.R.C., Y.M., S.H.) and School of Mathematical Sciences (D.Y., S.Z.), Tel-Aviv University, Tel-Aviv, Israel; and Neuro- Oncology Service (D.T.B., F.B.) and Stereotactic Radiosurgery Unit (A.A.K.), Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
C. Hoffmann
From the Oncology Institute (L.Z., A.T.), Advanced Technology Center (D.G., D.L., D.D., S.S., Y.M.), Department of Neurosurgery (Z.R.C., S.H.), Radiology Institute (C.H., G.T.), and Pathology Institute (D.N.), Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine (L.Z., D.D., C.H., G.T., Z.R.C., Y.M., S.H.) and School of Mathematical Sciences (D.Y., S.Z.), Tel-Aviv University, Tel-Aviv, Israel; and Neuro- Oncology Service (D.T.B., F.B.) and Stereotactic Radiosurgery Unit (A.A.K.), Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
D. Nass
From the Oncology Institute (L.Z., A.T.), Advanced Technology Center (D.G., D.L., D.D., S.S., Y.M.), Department of Neurosurgery (Z.R.C., S.H.), Radiology Institute (C.H., G.T.), and Pathology Institute (D.N.), Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine (L.Z., D.D., C.H., G.T., Z.R.C., Y.M., S.H.) and School of Mathematical Sciences (D.Y., S.Z.), Tel-Aviv University, Tel-Aviv, Israel; and Neuro- Oncology Service (D.T.B., F.B.) and Stereotactic Radiosurgery Unit (A.A.K.), Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
A. Talianski
From the Oncology Institute (L.Z., A.T.), Advanced Technology Center (D.G., D.L., D.D., S.S., Y.M.), Department of Neurosurgery (Z.R.C., S.H.), Radiology Institute (C.H., G.T.), and Pathology Institute (D.N.), Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine (L.Z., D.D., C.H., G.T., Z.R.C., Y.M., S.H.) and School of Mathematical Sciences (D.Y., S.Z.), Tel-Aviv University, Tel-Aviv, Israel; and Neuro- Oncology Service (D.T.B., F.B.) and Stereotactic Radiosurgery Unit (A.A.K.), Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
G. Tsarfaty
From the Oncology Institute (L.Z., A.T.), Advanced Technology Center (D.G., D.L., D.D., S.S., Y.M.), Department of Neurosurgery (Z.R.C., S.H.), Radiology Institute (C.H., G.T.), and Pathology Institute (D.N.), Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine (L.Z., D.D., C.H., G.T., Z.R.C., Y.M., S.H.) and School of Mathematical Sciences (D.Y., S.Z.), Tel-Aviv University, Tel-Aviv, Israel; and Neuro- Oncology Service (D.T.B., F.B.) and Stereotactic Radiosurgery Unit (A.A.K.), Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
S. Salomon
From the Oncology Institute (L.Z., A.T.), Advanced Technology Center (D.G., D.L., D.D., S.S., Y.M.), Department of Neurosurgery (Z.R.C., S.H.), Radiology Institute (C.H., G.T.), and Pathology Institute (D.N.), Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine (L.Z., D.D., C.H., G.T., Z.R.C., Y.M., S.H.) and School of Mathematical Sciences (D.Y., S.Z.), Tel-Aviv University, Tel-Aviv, Israel; and Neuro- Oncology Service (D.T.B., F.B.) and Stereotactic Radiosurgery Unit (A.A.K.), Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
A.A. Kanner
From the Oncology Institute (L.Z., A.T.), Advanced Technology Center (D.G., D.L., D.D., S.S., Y.M.), Department of Neurosurgery (Z.R.C., S.H.), Radiology Institute (C.H., G.T.), and Pathology Institute (D.N.), Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine (L.Z., D.D., C.H., G.T., Z.R.C., Y.M., S.H.) and School of Mathematical Sciences (D.Y., S.Z.), Tel-Aviv University, Tel-Aviv, Israel; and Neuro- Oncology Service (D.T.B., F.B.) and Stereotactic Radiosurgery Unit (A.A.K.), Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
D.T. Blumenthal
From the Oncology Institute (L.Z., A.T.), Advanced Technology Center (D.G., D.L., D.D., S.S., Y.M.), Department of Neurosurgery (Z.R.C., S.H.), Radiology Institute (C.H., G.T.), and Pathology Institute (D.N.), Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine (L.Z., D.D., C.H., G.T., Z.R.C., Y.M., S.H.) and School of Mathematical Sciences (D.Y., S.Z.), Tel-Aviv University, Tel-Aviv, Israel; and Neuro- Oncology Service (D.T.B., F.B.) and Stereotactic Radiosurgery Unit (A.A.K.), Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
F. Bokstein
From the Oncology Institute (L.Z., A.T.), Advanced Technology Center (D.G., D.L., D.D., S.S., Y.M.), Department of Neurosurgery (Z.R.C., S.H.), Radiology Institute (C.H., G.T.), and Pathology Institute (D.N.), Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine (L.Z., D.D., C.H., G.T., Z.R.C., Y.M., S.H.) and School of Mathematical Sciences (D.Y., S.Z.), Tel-Aviv University, Tel-Aviv, Israel; and Neuro- Oncology Service (D.T.B., F.B.) and Stereotactic Radiosurgery Unit (A.A.K.), Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
S. Harnof
From the Oncology Institute (L.Z., A.T.), Advanced Technology Center (D.G., D.L., D.D., S.S., Y.M.), Department of Neurosurgery (Z.R.C., S.H.), Radiology Institute (C.H., G.T.), and Pathology Institute (D.N.), Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine (L.Z., D.D., C.H., G.T., Z.R.C., Y.M., S.H.) and School of Mathematical Sciences (D.Y., S.Z.), Tel-Aviv University, Tel-Aviv, Israel; and Neuro- Oncology Service (D.T.B., F.B.) and Stereotactic Radiosurgery Unit (A.A.K.), Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
D. Yekutieli
From the Oncology Institute (L.Z., A.T.), Advanced Technology Center (D.G., D.L., D.D., S.S., Y.M.), Department of Neurosurgery (Z.R.C., S.H.), Radiology Institute (C.H., G.T.), and Pathology Institute (D.N.), Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine (L.Z., D.D., C.H., G.T., Z.R.C., Y.M., S.H.) and School of Mathematical Sciences (D.Y., S.Z.), Tel-Aviv University, Tel-Aviv, Israel; and Neuro- Oncology Service (D.T.B., F.B.) and Stereotactic Radiosurgery Unit (A.A.K.), Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
S. Zamir
From the Oncology Institute (L.Z., A.T.), Advanced Technology Center (D.G., D.L., D.D., S.S., Y.M.), Department of Neurosurgery (Z.R.C., S.H.), Radiology Institute (C.H., G.T.), and Pathology Institute (D.N.), Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine (L.Z., D.D., C.H., G.T., Z.R.C., Y.M., S.H.) and School of Mathematical Sciences (D.Y., S.Z.), Tel-Aviv University, Tel-Aviv, Israel; and Neuro- Oncology Service (D.T.B., F.B.) and Stereotactic Radiosurgery Unit (A.A.K.), Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Z.R. Cohen
From the Oncology Institute (L.Z., A.T.), Advanced Technology Center (D.G., D.L., D.D., S.S., Y.M.), Department of Neurosurgery (Z.R.C., S.H.), Radiology Institute (C.H., G.T.), and Pathology Institute (D.N.), Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine (L.Z., D.D., C.H., G.T., Z.R.C., Y.M., S.H.) and School of Mathematical Sciences (D.Y., S.Z.), Tel-Aviv University, Tel-Aviv, Israel; and Neuro- Oncology Service (D.T.B., F.B.) and Stereotactic Radiosurgery Unit (A.A.K.), Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
L. Zach
From the Oncology Institute (L.Z., A.T.), Advanced Technology Center (D.G., D.L., D.D., S.S., Y.M.), Department of Neurosurgery (Z.R.C., S.H.), Radiology Institute (C.H., G.T.), and Pathology Institute (D.N.), Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine (L.Z., D.D., C.H., G.T., Z.R.C., Y.M., S.H.) and School of Mathematical Sciences (D.Y., S.Z.), Tel-Aviv University, Tel-Aviv, Israel; and Neuro- Oncology Service (D.T.B., F.B.) and Stereotactic Radiosurgery Unit (A.A.K.), Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Y. Mardor
From the Oncology Institute (L.Z., A.T.), Advanced Technology Center (D.G., D.L., D.D., S.S., Y.M.), Department of Neurosurgery (Z.R.C., S.H.), Radiology Institute (C.H., G.T.), and Pathology Institute (D.N.), Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine (L.Z., D.D., C.H., G.T., Z.R.C., Y.M., S.H.) and School of Mathematical Sciences (D.Y., S.Z.), Tel-Aviv University, Tel-Aviv, Israel; and Neuro- Oncology Service (D.T.B., F.B.) and Stereotactic Radiosurgery Unit (A.A.K.), Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Data supplements
Files in this Data Supplement:
Advertisement
Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade Gliomas
D. Daniels, D. Guez, D. Last, C. Hoffmann, D. Nass, A. Talianski, G. Tsarfaty, S. Salomon, A.A. Kanner, D.T. Blumenthal, F. Bokstein, S. Harnof, D. Yekutieli, S. Zamir, Z.R. Cohen, L. Zach, Y. Mardor
American Journal of Neuroradiology Jul 2016, DOI: 10.3174/ajnr.A4866
Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade Gliomas
D. Daniels, D. Guez, D. Last, C. Hoffmann, D. Nass, A. Talianski, G. Tsarfaty, S. Salomon, A.A. Kanner, D.T. Blumenthal, F. Bokstein, S. Harnof, D. Yekutieli, S. Zamir, Z.R. Cohen, L. Zach, Y. Mardor
American Journal of Neuroradiology Jul 2016, DOI: 10.3174/ajnr.A4866
Jump to section
Related Articles
Cited By...
- No citing articles found.
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement